ID   LB796-BLC
AC   CVCL_E906
SY   LB796
DR   Wikidata; Q54902084
RX   PubMed=11051255;
RX   PubMed=29732388;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
RX   PubMed=11051255;
RA   Gala J.-L., Loric S., Guiot Y., Denmeade S.R., Gady A., Brasseur F.,
RA   Heusterspreute M., Eschwege P., De Nayer P., Van Cangh P.J., Tombal B.;
RT   "Expression of prostate-specific membrane antigen in transitional cell
RT   carcinoma of the bladder: prognostic value?";
RL   Clin. Cancer Res. 6:4049-4054(2000).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//